KATO Mitsuyasu

Researcher's full information

Articles
  • Expression of TGF-β type I and type II receptors in rat eyes.
    Obata H; Kaburaki T; Kato M; Yamashita H
    Curr. Eye Res./15/pp.335-340, 1996-01
  • Distribution of transforming growth factor-β and its receptors in gastric carcinoma tissue.
    Kai T; Taketazu F; Kawakami M; Shimanuki K; Yamada S; Miy...
    Jpn. J. Cancer Res./87/pp.296-304, 1996-01
  • Genetic change in transforming growth factor-β(TGF-β) receptor type I gene correlates with insensitivity to TGF-β1 in human prostatic cancer cells.
    Kim IY; Ahn H-J; Zelner DJ; Shaw JW; Sensibar JA; Kim J-...
    Cancer Res./56/pp.44-48, 1996-01
  • Bone morphogenetic protein type IB receptor is progressively expressed in malignant glioma tumours.
    Yamada N; Kato M; ten Dijke P; Yamashita H; Sampath TK; H...
    Br. J. Cancer/73/pp.624-629, 1996-01
  • A human keratinocyte cell line produces two autocrine growth inhibitors, transforming growth factor-β and insulin-like growth factor binding protein-6, in a calcium- and cell density-dependent manner.
    Kato M; Hellman U; Wernstedt C; Kyougoku M; Miyazono K; H...
    J. Biol. Chem./270/pp.12373-12379, 1995-01
  • Enhanced expression of transforming growth factor-β(TGF-β) and its Type I and type II receptors in human glioblastoma.
    Yamada N; Kato M; Yamashita H; Nister M; Heldin C-H; Miya...
    Int. J. Cancer/62/pp.386-392, 1995-01
  • Characterization of keratinocytes-derived autocrine growth inhibitors.
    Kato M; Hellman U; Wernstedt C; Miyazono K; Heldin C-H; F...
    Proceedings of the XVI international cancer congress/pp.3035-3039, 1994-01
  • Diffetential localization of TGF-β-precursor isotypes in normal human skin.
    Wataya-Kaneda M; Hashimoto K; Kato M; Miyazono K; Yoshika...
    J. Dermatol. Sci./8/pp.38-44, 1994-01
  • Enhanced expression of transforming growth factor-βs and transforming growth factor-β type II receptor in the synovial tissues of patients with rheumatoid arthritis.
    Taketazu F; Kato M; Gobl A; Ichijo H; ten Dijke P; Itoh ...
    Lab. Invest./70/pp.620-630, 1994-01
  • Immunopathological features of palatine tonsil characteristic of IgA nephropathy.
    Kusakari C; Nose M; Takasaka T; Yuasa R; Kato M; Miyazono...
    Clin. Exp. Immunol./95/pp.42-48, 1994-01
  • Expression of decay accelerating factor is reduced on hyperplastic synovial lining cells in rheumatoid synovitis.
    Itoh J; Nose M; Fujita T; Kato M; Ohyama A; Kyogoku M
    Clin. Exp. Immunol./83/pp.364-368, 1991-01
  • Neurotropic activity of platelet-derived growth factor(PDGF): rat neuronal cells possess functional PDGF β-type receptors and respond to PDGF.
    Smits A; Kato M; Westermark B; Nister M; Heldin C-H; Funa K
    Proc. Natl. Acad. Sci. USA/88/pp.8159-8163, 1991-01
  • Tissue distribution of HRF 20, a novel factor preventing the membrane attack of homologous complement, and its predominant expression on endothelial cells in vivo.
    Nose M; Kato M; Okada N; Kyougoku M; Okada H
    Immunology/70/pp.145-149, 1990-01
  • Competence growth factors evoke the phenotypic transition of arterial smooth muscle cells.
    Kato M; Kyogoku M
    Ann. N.Y. Acad. Sci./598/pp.232-237, 1990-01
  • Experimental studies on the factors to control endoarterial proliferation in repair of arteritis.
    Kato M; Fujiyama M; Kyogoku M
    J. Pharmacobio-Dyn./12/p.s-103, 1989-01